Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

July

30

Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock

Alphatec Holdings begins the underwriting public offering process with intent of using proceeds for...

10

Multiple Abstracts Highlighting Non-Invasive Vagus Nerve Stimulation (NVNS) to be Presented at the American Headache Society’s 61st Annual Scientific Meeting

July 11 – July 14, 2019 at the Pennsylvania Convention Center in Philadelphia BASKING...

9

NICE Issues Draft Guidelines on the use of GammaCore for Cluster Headache

The UK’s National Institute for Health and Care Excellence (NICE) draft guidance recommends the...

27

AlphaTec Announces Organizational and Corporate Updates

New Appointment to Board of Directors Inclusion in Russell 2000® Index Drawdown on Squadron Credit...

27

TriSalus Life Sciences forms World-Class Scientific Advisory Board to Accelerate Advancement of Strategy to Deliver Therapeutics to Solid Tumors

New Board compromised of preeminent experts across medical, surgical and radiation oncology, as well...

24

ElectroCore Announces GammaCore Listing on the NHS Supply Chain Catalogue

Provides UK-based primary headache patients not eligible for the Innovation Technology Payment scheme (reserved...

19

SupplyPro Feautured in Technology Headlines Magazine’s May 2019 Issue

10 Fastest growing inventory management solution providers to watch in 2019 http://www.supplypro.com/Content/pdfs/Inventory_CoverStory.pdf...

30

AlphaTec Announces Commercial Launch of TLIF IndentiTi™ Posterior Curved Porous Titanium Interbody Implant System

Innovative machine marks the fourth of twelve new product launches planned for 2019, and...

20

UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.

– NAYZILAM® (midazolam) nasal spray CIV is a nasally administered benzodiazepine indicated for the...

24

Exagen’s New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers

Lupus patients with elevated PC4d Levels have significantly increased occurrence of Thrombosis SAN DIEGO,...

15

AlphaTec Announces Sales Leadership Appointment and Succesful Closing of Expanded Credit Facility with Squadron Capital

Experienced spine executive David Sponsel assumes sales leadership role CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE)...

28

AlphaTec Announces Commercial Launch of its First IndentiTi™ Porous Titanium Interbody System

IndetiTi implants are 60% porous, which enhances intra-operative and post-operative imaging CARLSBAD, Calif., March 28,...

Recent developments

News

July

30

Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock

July

10

Multiple Abstracts Highlighting Non-Invasive Vagus Nerve Stimulation (NVNS) to be Presented at the American Headache Society’s 61st Annual Scientific Meeting

July

9

NICE Issues Draft Guidelines on the use of GammaCore for Cluster Headache

June

27

AlphaTec Announces Organizational and Corporate Updates

June

27

TriSalus Life Sciences forms World-Class Scientific Advisory Board to Accelerate Advancement of Strategy to Deliver Therapeutics to Solid Tumors

June

24

ElectroCore Announces GammaCore Listing on the NHS Supply Chain Catalogue

June

19

SupplyPro Feautured in Technology Headlines Magazine’s May 2019 Issue

May

30

AlphaTec Announces Commercial Launch of TLIF IndentiTi™ Posterior Curved Porous Titanium Interbody Implant System

May

20

UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.

April

24

Exagen’s New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers

April

15

AlphaTec Announces Sales Leadership Appointment and Succesful Closing of Expanded Credit Facility with Squadron Capital

March

28

AlphaTec Announces Commercial Launch of its First IndentiTi™ Porous Titanium Interbody System